New patent grants

RNS Number : 9202Z
Directa Plus PLC
23 May 2019
 

23 May 2019

 

Directa Plus plc

("Directa Plus" or the "Company")

 

New patent grants

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene-based products for use in consumer and industrial markets, is pleased to announce that the Company has been granted two new patents, for the application of the Company's G+ graphene products.

 

Graphene enhanced golf balls

 

The first is an Italian patent for the use of the Company's G+ graphene in the manufacture of golf balls. The use of the G+ compounds in golf balls, can provide a series of beneficial features that offer opportunities to develop a new generation of golf ball, both for professional and amateur players.

 

Certain G+ compounds will be able to achieve particular qualities when added to golf balls.

 

G+ materials can be used to enhance the hard core of professional golf balls in order to increase the shot distance potential of the ball, without losing lateral control. In addition, G+ can be used in the amateur golf ball market, to guarantee swing and improved control.

 

Preparing Graphene Nanoplatelets

 

The second is a Chinese patent, covering Directa Plus' unique process for the manufacturing graphene nanoplatelets.

Directa Plus's unique exfoliation technology is chemical free, has an extremely high yield, and can be varied to produce graphene nanoplatelets with specific morphologies. This means that G+ products are safe for human health, can be tailor-made to meet customers' needs, and the high-yields create competitive prices.

Additionally, the unique characteristics of the G+ process, allow the Company to enter large supply chains, in turn overcoming important entry barriers into the market.

 

Commenting on the agreement, Giulio Cesareo, Founder and CEO of Directa Plus, said:

 

"I'm very pleased that we were able to secure two new patents. We continue to show how our G+ graphene nanoplatelets can enhance products in various categories, and it is vital that we secure the Intellectual Property rights needed to protect our unique technology in worldwide jurisdictions.

 

"Securing Intellectual Property rights for our technological innovations is a key part of our corporate strategy - across global jurisdictions. The Company's current suite of patents now includes 22 granted, and a further 22 pending approval."

 

"Using our G+ product in golf balls, for both the amateur and professional game is an exciting opportunity to enter a large sporting market. "

 

"Additionally, gaining legal recognition of the Company's proprietary, chemical-free graphene production process in China will allow us to enter into larger Chinese supply chains more easily and overcome these barriers in the future."

 

 

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

 

 

Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)

+44 20 7894 7000

Rick Thompson, Philip Davies Will Goode (Corporate Finance)

 

Caspar Shand Kydd (Sales)

 

 

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Mark Taylor, Lauren Kettle

 

 

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson, Barnaby Hayward, Edward Lee

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products).  In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products.  All our products are hypoallergenic, non-toxic and sustainably produced.

 

-ends-


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRASEEEEEFUSEFI
UK 100

Latest directors dealings